We only have this paper's title and publication details.
Read it at the sourceRandomized trial investigates siponimod's impact on cognitive processing speed in patients with secondary progressive multiple sclerosis, suggesting its efficacy.
No takes yet. Share an insight, caveat, or question.
Benedict et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: